RWE and HTA – a snapshot of recent developments with Sreeram Ramagopalan: April–May 2022

5 Jul 2022

Written by Sreeram Ramagopalan (F. Hoffmann-La Roche)

Guest columns Health technology assessment Industry Updates Interviews Journal articles Outcomes research Real-world evidence Regulation

Read highlights from the latest instalment of Sreeram Ramagopalan’s (F. Hoffman La Roche, Basel, Switzerland) industry news round-up, which discusses some of the latest developments regarding real-world evidence (RWE) in the context of health technology assessment (HTA) and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update for April–May 2022 in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? The publication of the National Institute for Health and Care Excellence (NICE; London, UK) RWE framework. The framework provides in-depth guidance surrounding the planning,...